Works matching DE "EMTRICITABINE-tenofovir"
Results: 351
Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Effect of hepatitis B and C clearance on atazanavir exposure.
- Published in:
- 2015
- By:
- Publication type:
- Letter
THE EFFECT OF EMTRICITABINE AND TENOFOVIR USE IN THE PRE-EXPOSURE PROFYLAXIS (PrEP) FOR HIV TRANSMISSION.
- Published in:
- Health & Research Journal, 2020, v. 6, n. 4, p. 101, doi. 10.12681/healthresj.25625
- By:
- Publication type:
- Article
Acute Psychiatric Disorders Related to Fake Cathinone: Ephylone.
- Published in:
- Journal of Analytical Toxicology, 2019, v. 43, n. 7, p. e1, doi. 10.1093/jat/bkz020
- By:
- Publication type:
- Article
HIV: What Family Medicine Clinicians Need to Know.
- Published in:
- Family Doctor: A Journal of the New York State Academy of Family Physicians, 2020, v. 8, n. 3, p. 34
- By:
- Publication type:
- Article
Let's Talk About PrEP -- A Powerful Tool for Sexual Health.
- Published in:
- Family Doctor: A Journal of the New York State Academy of Family Physicians, 2018, v. 6, n. 3, p. 32
- By:
- Publication type:
- Article
The Downstream Impacts of High Drug Costs for PrEP Have Hindered the Promise of HIV Prevention.
- Published in:
- Journal of Law, Medicine & Ethics, 2022, v. 50, p. 47, doi. 10.1017/jme.2022.35
- By:
- Publication type:
- Article
Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies.
- Published in:
- Clinical & Translational Medicine, 2018, v. 7, n. 1, p. 1, doi. 10.1186/s40169-018-0213-6
- By:
- Publication type:
- Article
InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
- Published in:
- HIV Medicine, 2018, v. 19, n. 1, p. 1, doi. 10.1111/hiv.12528
- By:
- Publication type:
- Article
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.
- Published in:
- HIV Medicine, 2017, v. 18, n. 7, p. 474, doi. 10.1111/hiv.12478
- By:
- Publication type:
- Article
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
- Published in:
- HIV Medicine, 2017, v. 18, n. 7, p. 482, doi. 10.1111/hiv.12479
- By:
- Publication type:
- Article
Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands ( ATHENA) cohort.
- Published in:
- HIV Medicine, 2016, v. 17, n. 8, p. 571, doi. 10.1111/hiv.12355
- By:
- Publication type:
- Article
Comparative risk of failure of ABC/3 TC or TDF/ FTC based first-line regimens in patients with a high viral load.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 380, doi. 10.1111/hiv.12306
- By:
- Publication type:
- Article
Pharmacokinetics of tenofovir during pregnancy and postpartum.
- Published in:
- HIV Medicine, 2015, v. 16, n. 8, p. 502, doi. 10.1111/hiv.12252
- By:
- Publication type:
- Article
Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.
- Published in:
- HIV Medicine, 2015, v. 16, n. 6, p. 370, doi. 10.1111/hiv.12210
- By:
- Publication type:
- Article
Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapy.
- Published in:
- HIV Medicine, 2014, v. 15, n. 10, p. 611, doi. 10.1111/hiv.12157
- By:
- Publication type:
- Article
Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 13, doi. 10.1111/hiv.12075
- By:
- Publication type:
- Article
Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.
- Published in:
- HIV Medicine, 2013, v. 14, n. 6, p. 327, doi. 10.1111/hiv.12011
- By:
- Publication type:
- Article
Pharmacokinetics and food interaction of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy volunteers.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2013, v. 38, n. 2, p. 136, doi. 10.1111/jcpt.12023
- By:
- Publication type:
- Article
Mobilization of systemic CCL4 following HIV preexposure prophylaxis in young men in Africa.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.965214
- By:
- Publication type:
- Article
Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PrEP on Twitter: Information, Barriers, and Stigma.
- Published in:
- Health Communication, 2017, v. 32, n. 4, p. 509, doi. 10.1080/10410236.2016.1140271
- By:
- Publication type:
- Article
Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter.
- Published in:
- Health Communication, 2016, v. 31, n. 8, p. 998, doi. 10.1080/10410236.2015.1027033
- By:
- Publication type:
- Article
Effectiveness, durability and safety of dolutegravir and lamivudine versus bictegravir, emtricitabine and tenofovir alafenamide in a real-world cohort of HIV-infected adults.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291480
- By:
- Publication type:
- Article
La place du médecin généraliste dans la gestion de la prophylaxie pré-exposition au VIH (PrEP). Étude qualitative auprès des patients sous PrEP de Béarn et Soule.
- Published in:
- Médecine, 2022, v. 18, n. 6, p. 266, doi. 10.1684/med.2022.783
- By:
- Publication type:
- Article
COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 4953, doi. 10.3390/ijms21144953
- By:
- Publication type:
- Article
HIV post exposure prophylaxis induced bicytopenia: a case report.
- Published in:
- AIDS Research & Therapy, 2014, v. 11, p. 2, doi. 10.1186/1742-6405-11-11
- By:
- Publication type:
- Article
Current status of the HIV epidemic & challenges in prevention.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Integrating Behavioral HIV Interventions Into Biomedical Prevention Trials With Youth: Lessons From Chicago's Project PrEPare.
- Published in:
- Journal of HIV/AIDS & Social Services, 2013, v. 12, n. 3/4, p. 333, doi. 10.1080/15381501.2013.773575
- By:
- Publication type:
- Article
Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa.
- Published in:
- PLoS Medicine, 2013, v. 10, n. 9, p. 1, doi. 10.1371/journal.pmed.1001511
- By:
- Publication type:
- Article
Breakthrough HIV viraemia on bictegravir/emtricitabine/tenofovir alafenamide in the third trimester of pregnancy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2390, doi. 10.1093/jac/dkae197
- By:
- Publication type:
- Article
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 7, p. 1706, doi. 10.1093/jac/dkae115
- By:
- Publication type:
- Article
Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 1, p. 161, doi. 10.1093/jac/dkac369
- By:
- Publication type:
- Article
Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pharmacokinetics of bictegravir, emtricitabine and tenofovir alafenamide in a gastrectomized patient with HIV.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Three-year study of pre-existing drug resistance substitutions and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in HIV-1 treatment-naive participants.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother--infant pairs.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2018, v. 73, n. 4, p. 1013, doi. 10.1093/jac/dkx507
- By:
- Publication type:
- Article
High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Bulevirtide plus Tenofovir Disoproxil Fumarate Improves Liver Function in HDV/HBV Related Cirrhosis after Virological Response: A Case Report.
- Published in:
- Gastrointestinal Disorders, 2022, v. 4, n. 4, p. 277, doi. 10.3390/gidisord4040026
- By:
- Publication type:
- Article
Adaptation of a HIV Prevention Mobile App for Transmasculine People: A Pilot Acceptability and Feasibility Study.
- Published in:
- Transgender Health, 2024, v. 9, n. 6, p. 573, doi. 10.1089/trgh.2023.0041
- By:
- Publication type:
- Article
Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial.
- Published in:
- Transgender Health, 2024, v. 9, n. 1, p. 46, doi. 10.1089/trgh.2022.0048
- By:
- Publication type:
- Article
Evaluation of chromatographic conditions for simultaneously determination of Emtricitabine and Tenofovir.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 101, doi. 10.33320/maced.pharm.bull.2022.68.03.046
- By:
- Publication type:
- Article
Capturing public interest toward new tools for controlling human immunodeficiency virus (HIV) infection exploiting data from Google Trends.
- Published in:
- Health Informatics Journal, 2019, v. 25, n. 4, p. 1383, doi. 10.1177/1460458218766573
- By:
- Publication type:
- Article